142 related articles for article (PubMed ID: 29978574)
1. Soluble galectin 9 potently enhanced regulatory T-cell formation, a pathway impaired in patients with intracranial aneurysm.
Zhao MG; Liang GB; Zhang HF; Zhao GF; Luo YH
Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1206-1212. PubMed ID: 29978574
[TBL] [Abstract][Full Text] [Related]
2. Patients with intracranial aneurysms presented defects in regulatory T cells, which were associated with impairment in Tim-3 upregulation.
Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
Int Immunopharmacol; 2018 Nov; 64():350-355. PubMed ID: 30243071
[TBL] [Abstract][Full Text] [Related]
3. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells demonstrate significantly increased functions following stimulation with IL-2 in a Tim-3-dependent manner in intracranial aneurysms.
Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
Int Immunopharmacol; 2018 Dec; 65():342-347. PubMed ID: 30366277
[TBL] [Abstract][Full Text] [Related]
5. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
[TBL] [Abstract][Full Text] [Related]
7. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
[TBL] [Abstract][Full Text] [Related]
8. Fecal bacteria from ulcerative colitis patients downregulate Tim-3-mediated inhibitory effects on monocytes in vitro.
Wang S; Liu Y; Yuan X; Yao L; Yang S; Ma R
Microb Pathog; 2019 Mar; 128():147-152. PubMed ID: 30594639
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.
Ma Q; Liu J; Wu G; Teng M; Wang S; Cui M; Li Y
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1002-1009. PubMed ID: 29905955
[TBL] [Abstract][Full Text] [Related]
10. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
11. Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.
Hu X; Zhu Q; Wang Y; Wang L; Li Z; Mor G; Liao A
Hum Reprod; 2020 Nov; 35(11):2454-2466. PubMed ID: 33107565
[TBL] [Abstract][Full Text] [Related]
12. Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype.
Li ZH; Wang LL; Liu H; Muyayalo KP; Huang XB; Mor G; Liao AH
Front Immunol; 2018; 9():3142. PubMed ID: 30687334
[TBL] [Abstract][Full Text] [Related]
13. Cis association of galectin-9 with Tim-3 differentially regulates IL-12/IL-23 expressions in monocytes via TLR signaling.
Ma CJ; Li GY; Cheng YQ; Wang JM; Ying RS; Shi L; Wu XY; Niki T; Hirashima M; Li CF; Moorman JP; Yao ZQ
PLoS One; 2013; 8(8):e72488. PubMed ID: 23967307
[TBL] [Abstract][Full Text] [Related]
14. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
15. Conjugated Bilirubin Upregulates TIM-3 Expression on CD4
Trujillo-Ochoa JL; Corral-Jara KF; Charles-Niño CL; Panduro A; Fierro NA
Viral Immunol; 2018 Apr; 31(3):223-232. PubMed ID: 29099687
[TBL] [Abstract][Full Text] [Related]
16. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression.
Wang Z; Yin N; Zhang Z; Zhang Y; Zhang G; Chen W
Immunol Invest; 2017 Feb; 46(2):134-148. PubMed ID: 27911104
[TBL] [Abstract][Full Text] [Related]
18. Gal-9/Tim-3 signaling pathway activation suppresses the generation of Th17 cells and promotes the induction of Foxp3
Wang Y; Feng T; Li H; Xiong Y; Tao Y
Mol Immunol; 2023 Apr; 156():136-147. PubMed ID: 36921488
[TBL] [Abstract][Full Text] [Related]
19. Elevated Galectin-9 Suppresses Th1 Effector Function and Induces Apoptosis of Activated CD4
Yang S; Wang J; Chen F; Liu G; Weng Z; Chen J
Inflammation; 2017 Jun; 40(3):1062-1071. PubMed ID: 28393295
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.
Zhang W; Zhang Y; He Y; Wang X; Fang Q
Exp Cell Res; 2019 Mar; 376(2):124-132. PubMed ID: 30763585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
